If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksZotefoams Plc Regulatory News (ZTF)

Share Price Information for Zotefoams Plc (ZTF)

Share Price is delayed by 15 minutes
Get Live Data
455.00    18.00 (4.12%)
Bid:
453.00
Ask:
459.00
Spread: 6.00 (1.325%)
Market Cap: £223.78m
ZTF Live PriceLast checked at - London Stock Exchange

Intraday Zotefoams Plc Share Chart

Trading Update and Interim Management Statement

23 Oct 2013 07:00

RNS Number : 1453R
Zotefoams PLC
23 October 2013
 



23 October 2013

 

 

Zotefoams plc

("Zotefoams" or "the Company")

 

Trading Update and Interim Management Statement for the Quarter ended 30 September 2013

 

Zotefoams plc (the "Company"), a world leader in cellular material technology, today announces a trading update and its interim management statement for the third quarter ended 30 September 2013.

Growth in sales of High-Performance Products ("HPP") products and Azote® polyolefin foams in Asia in the third quarter has been offset by an unexpected shortfall in shipments to some European polyolefin customers, leaving total sales in the quarter at the same level as 2012 and below the level previously anticipated. These falls are, in the main, related to larger customers who are responding to continued destocking in the downstream market, which affects their demand levels in the short-term. The Board considers it prudent to assume that this trend will continue for the remainder of the year but, with the benefit of our shorter lead times, we expect to progress in this market in 2014.

Our HPP products business continues to grow strongly with long-term projects giving positive momentum into 2014 and beyond.

MuCell Extrusion, our technology licensing business, is focusing increasingly on consumer packaging. Given the scale of this opportunity further investment in our technology is being made during the fourth quarter.

Foreign currency rates have been less favourable in the third quarter compared to the first half of 2013 and the adverse impact in this period, mainly due to our US-dollar denominated investments, is in the region of £0.4 million.

The overall impact of these factors is that the Company expects second half profit to be below the level seen in the first half and therefore profit for the year to be below previous management expectations.

Although it is disappointing to see the current shortfall in European polyolefin foams, the Board considers the impact to be short-term and is encouraged by the performance of the business elsewhere. A return to growth is expected in 2014, and the Board remains confident in the long-term prospects for the business.

 

 

Enquiries:

Zotefoams plc

0208-664-1600

David Stirling, Managing Director

Clifford Hurst, Finance Director

FTI Consulting

0207-831-3113

John Dineen, Victoria Foster Mitchell

 

 

About Zotefoams plc

Zotefoams plc (LSE - ZTF) is a world leader in cellular material technology. Using a unique manufacturing process with environmentally friendly nitrogen expansion, Zotefoams produces lightweight foams in Croydon, UK and Kentucky, USA for diverse markets worldwide through its global sales force. Zotefoams also owns and licenses patented MuCell® microcellular foam technology from a base in Massachusetts, USA to customers worldwide and sells T-Tubes® advanced insulation systems made from its patented ZOTEK® fluoropolymer foams.

 

www.zotefoams.com

 

ZOTEK®, Azote® and microZOTE® are registered trademarks of Zotefoams plc. MuCell® is a registered trademark of Trexel Inc. T-Tubes® is a registered trademark of UFP Technologies Inc.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCMTBRTMBBTBJJ
Date   Source Headline
8th Sep 20153:56 pmRNSDirector/PDMR Shareholding
7th Aug 20159:00 amRNSDirector/PDMR Shareholding
4th Aug 20157:00 amRNSHalf Yearly Report
10th Jul 20157:00 amRNSTrading Update
9th Jul 201511:38 amRNSHolding(s) in Company
2nd Jul 20157:30 amRNSDirector Declaration
23rd Jun 20154:08 pmRNSHolding(s) in Company
22nd Jun 20154:58 pmRNSHolding(s) in Company
22nd Jun 20152:39 pmRNSHolding(s) in Company
27th May 20158:57 amRNSHolding(s) in Company
13th May 20153:00 pmRNSResult of AGM
13th May 20157:00 amRNSAGM Trading Update
13th Apr 20153:22 pmRNSDirector/PDMR Shareholding
10th Apr 20159:30 amRNSAnnual Report and Notice of AGM
31st Mar 20159:26 amRNSDirector/PDMR Shareholding
30th Mar 201510:55 amRNSHolding(s) in Company
27th Mar 20153:32 pmRNSHolding(s) in Company
23rd Mar 20158:40 amRNSHolding(s) in Company
17th Mar 20157:00 amRNSFinal Results
11th Mar 20153:51 pmRNSNew venture with China-based King Lai Group
16th Jan 20154:18 pmRNSNotification of Major Interest in Shares
9th Jan 20158:47 amRNSHolding(s) in Company
7th Jan 20157:00 amRNSTrading Update
7th Nov 20147:00 amRNSInterim Management Statement
20th Oct 20147:01 amRNSDirector Declaration
6th Oct 20142:07 pmRNSDirector/PDMR Shareholding
25th Sep 20147:00 amRNSAppointments of Non-executive Directors
19th Sep 201410:31 amRNSHolding(s) in Company
19th Sep 201410:30 amRNSHolding(s) in Company
17th Sep 20149:45 amRNSDirector/PDMR Shareholding
17th Sep 20149:41 amRNSTotal Voting Rights
16th Sep 20144:45 pmRNSHolding(s) in Company
12th Sep 20147:00 amRNSPlacing to raise approximately £8.8m
12th Aug 20147:00 amRNSHalf Yearly Report
29th Jul 201411:17 amRNSHolding(s) in Company
30th Jun 20147:00 amRNSTrading Statement
20th May 201412:59 pmRNSResult of AGM
19th May 20147:00 amRNSAGM Statement and Interim Management Statement
13th May 20143:31 pmRNSDirectorate Change
22nd Apr 201412:41 pmRNSUnilever to use MuCell technology for Dove bottles
14th Apr 20144:04 pmRNS2013 Annual Report & Accounts and Notice of AGM
9th Apr 20149:06 amRNSDirector/PDMR Shareholding
8th Apr 20148:16 amRNSDirector/PDMR Shareholding
18th Mar 20147:00 amRNSFinal Results
15th Jan 20147:00 amRNSTrading Update
19th Nov 20134:19 pmRNSHolding(s) in Company
23rd Oct 20137:00 amRNSTrading Update and Interim Management Statement
17th Oct 20131:21 pmRNSHolding(s) in Company
1st Oct 20132:13 pmRNSDirector Declaration
21st Aug 201312:15 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.